Prognostic assays for maintenance hemodialysis patients
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 2, 2017
Issued Date -
N/A
app pub date -
Oct 27, 2011
filing date -
Nov 1, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Described herein are methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For example, the presence of increased very small LDL concentration or decreased LDL particle size in blood-serum serves as a useful means for prognostic risk assessment and monitoring.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully